Tag: lateral flow assays industry

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Lateral Flow Assays Market Growth From $13.45 Billion In 2026 To $19.3 Billion By 2030 At A CAGR Of 9.5%#_x000D_

The lateral flow assays market has shown significant expansion in recent years. Its valuation is anticipated to increase from $12.29 billion in 2025 to $13.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. Throughout the preceding period, this market’s expansion was primarily propelled by factors including the escalating need for rapid diagnostic solutions, a broader scope of infectious disease testing, the widespread application of rapid test kits, the evolution of decentralized healthcare delivery, and increasing public awareness regarding early disease detection._x000D_

_x000D_

The lateral flow assays market is projected to experience substantial expansion over the upcoming years. This market is set to reach $19.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This anticipated growth during the forecast period is primarily driven by factors such as the rising uptake of home-based diagnostics, broader integration of digital health solutions, an escalating need for multiplex testing, increased funding into rapid diagnostic technologies, and a heightened emphasis on continuous disease monitoring. Key trends anticipated for this period encompass the growing acceptance of rapid point-of-care diagnostics, increased utilization of multiplex lateral flow assays, the expanding integration of digital LFA readers, the growth of veterinary and home-based testing applications, and an intensified focus on improving test sensitivity._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=26362783&type=smp&name=Lateral%20Flow%20Assays%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Lateral Flow Assays Market Industry Drivers: What’s Behind The Revenue Growth?#_x000D_

The widespread occurrence of infectious diseases globally significantly fuels the expansion of the lateral flow assay market. In developing countries, the frequent incidence of infectious diseases such as HIV and malaria, combined with inadequate healthcare systems and growing public awareness, is projected to accelerate the adoption of lateral flow assay testing. The recent COVID-19 pandemic has emphasized the necessity for early illness detection capabilities, which is expected to further drive market growth. For instance, in August 2024, data published by the UK Health Security Agency, a UK-based executive agency, indicated that in England, the UK Health Security Agency (UKHSA) recorded 368 measles cases in 2023. This figure represents a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands contributing 44% and London 33% of the cases, respectively. Therefore, the high prevalence of infectious diseases worldwide will continue to contribute to the growth of the lateral flow assay market._x000D_

_x000D_

#Lateral Flow Assays Market Segment Analysis Spotlighting Growth Areas#_x000D_

The lateral flow assays market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Kits And Reagents, Lateral Flow Readers _x000D_

2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays_x000D_

3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications_x000D_

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents _x000D_

2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers _x000D_

_x000D_

#Lateral Flow Assays Market Growth Trends: What’s Shaping The Future Outlook?_x000D_

Leading companies in the lateral flow assay market are concentrating on developing adaptable products, such as lateral flow readers, to facilitate on-the-go testing and establish a competitive advantage. A lateral flow reader is a compact instrument employed for the rapid and qualitative assessment of lateral flow assays, delivering effective results in various testing environments. For instance, in February 2024, Upfront Diagnostics, a UK-based healthcare company, introduced the Lateral Flow Test for Triaging Stroke Patients Next Year. This test, specifically designed for triaging stroke patients and known as LVOne, aims to considerably boost the speed and accuracy of stroke diagnosis in pre-hospital settings. The LVOne test is a rapid blood test that enables paramedics to detect strokes caused by large vessel occlusions (LVO) within 15 minutes. This swift identification is essential for promptly directing patients to specialized stroke centers where timely treatment can dramatically enhance outcomes and mitigate long-term disabilities._x000D_

_x000D_

#Lateral Flow Assays Market Top Companies Driving Competitive Growth#_x000D_

Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics _x000D_

_x000D_

#View The Full Lateral Flow Assays Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Lateral Flow Assays Market Global Footprint: Which Region Leads The Market?#_x000D_

North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Lateral Flow Assays Market From 2026 To 2030?

The lateral flow assays market size has exhibited robust growth in recent years. It is projected to expand from $12.29 billion in 2025 to $13.45 billion in 2026, indicating a compound annual growth rate (CAGR) of 9.4%. Historically, this market’s expansion can be attributed to increasing demand for rapid diagnostic solutions, expansion of infectious disease testing, widespread use of rapid test kits, growth of decentralized healthcare delivery, and rising awareness of early disease detection.

The lateral flow assays market is poised for robust expansion in the coming years, with projections indicating a rise to $19.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This anticipated growth during the forecast period is driven by several factors, including the rising acceptance of home-based diagnostics, the broadening integration of digital health, an increasing need for multiplex testing, escalating investments in rapid diagnostic technologies, and a heightened emphasis on real-time disease monitoring. Key trends shaping the market during this period encompass the wider embrace of rapid point-of-care diagnostics, the expanding utilization of multiplex lateral flow assays, the growing incorporation of digital LFA readers, the extension of veterinary and home-based testing solutions, and a stronger emphasis on improving test sensitivity.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6359&type=smp

What Influential Factors Are Boosting The Lateral Flow Assays Market Demand?

The widespread occurrence of infectious diseases across the globe is a significant factor contributing to the expansion of the lateral flow assay market. In developing countries, the high frequency of infectious diseases such as HIV and malaria, alongside inadequate healthcare infrastructure and rising public awareness, is projected to accelerate the uptake of lateral flow assay testing. The recent COVID-19 pandemic has underscored the critical need for early illness detection capabilities, which is expected to fuel market growth. For instance, in August 2024, according to data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023. This represented a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Therefore, the high prevalence of infectious diseases globally will continue to contribute to the growth of the lateral flow assay market.

How Is The Lateral Flow Assays Market Structured Across Different Market Segments?

The lateral flow assays market covered in this report is segmented –

1) By Type: Kits And Reagents, Lateral Flow Readers

2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays

3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents

2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers

What Trends Are Influencing The Lateral Flow Assays Market Outlook?

Leading companies in the lateral flow assay market are concentrating on creating adaptable products, such as lateral flow readers, to enable mobile testing and secure a competitive position. A lateral flow reader, a portable instrument, facilitates rapid and qualitative analysis of lateral flow assays, delivering effective results across diverse testing scenarios. For example, in February 2024, Upfront Diagnostics, a healthcare firm from the UK, introduced the Lateral Flow Test for Triaging Stroke Patients Next Year. This test, named LVOne and specifically designed for assessing stroke patients, aims to substantially improve the swiftness and precision of stroke diagnosis in pre-hospital environments. The LVOne test is a rapid blood analysis that enables paramedics to detect strokes caused by large vessel occlusions (LVO) within 15 minutes. This prompt identification is vital for expediting patients to specialized stroke facilities where timely intervention can dramatically better outcomes and lessen long-term disabilities.

Who Are The Firms Contributing To The Lateral Flow Assays Market Ecosystem?

Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics

Access The Complete Lateral Flow Assays Market Report:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Which Region Accounts For The Highest Share Of The Lateral Flow Assays Market?

North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Lateral Flow Assays Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Browse Through More Reports Similar to the Global Lateral Flow Assays Market 2026, By The Business Research Company

Lateral Flow Immunoassay Based Rapid Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Flow Meter Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-meter-global-market-report

Flow Chemistry Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-chemistry-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Lateral Flow Assays Market From 2026 To 2030?

The lateral flow assays market size has exhibited robust growth in recent years. It is projected to expand from $12.29 billion in 2025 to $13.45 billion in 2026, indicating a compound annual growth rate (CAGR) of 9.4%. Historically, this market’s expansion can be attributed to increasing demand for rapid diagnostic solutions, expansion of infectious disease testing, widespread use of rapid test kits, growth of decentralized healthcare delivery, and rising awareness of early disease detection.

The lateral flow assays market is poised for robust expansion in the coming years, with projections indicating a rise to $19.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This anticipated growth during the forecast period is driven by several factors, including the rising acceptance of home-based diagnostics, the broadening integration of digital health, an increasing need for multiplex testing, escalating investments in rapid diagnostic technologies, and a heightened emphasis on real-time disease monitoring. Key trends shaping the market during this period encompass the wider embrace of rapid point-of-care diagnostics, the expanding utilization of multiplex lateral flow assays, the growing incorporation of digital LFA readers, the extension of veterinary and home-based testing solutions, and a stronger emphasis on improving test sensitivity.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6359&type=smp

What Influential Factors Are Boosting The Lateral Flow Assays Market Demand?

The widespread occurrence of infectious diseases across the globe is a significant factor contributing to the expansion of the lateral flow assay market. In developing countries, the high frequency of infectious diseases such as HIV and malaria, alongside inadequate healthcare infrastructure and rising public awareness, is projected to accelerate the uptake of lateral flow assay testing. The recent COVID-19 pandemic has underscored the critical need for early illness detection capabilities, which is expected to fuel market growth. For instance, in August 2024, according to data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023. This represented a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Therefore, the high prevalence of infectious diseases globally will continue to contribute to the growth of the lateral flow assay market.

How Is The Lateral Flow Assays Market Structured Across Different Market Segments?

The lateral flow assays market covered in this report is segmented –

1) By Type: Kits And Reagents, Lateral Flow Readers

2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays

3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents

2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers

What Trends Are Influencing The Lateral Flow Assays Market Outlook?

Leading companies in the lateral flow assay market are concentrating on creating adaptable products, such as lateral flow readers, to enable mobile testing and secure a competitive position. A lateral flow reader, a portable instrument, facilitates rapid and qualitative analysis of lateral flow assays, delivering effective results across diverse testing scenarios. For example, in February 2024, Upfront Diagnostics, a healthcare firm from the UK, introduced the Lateral Flow Test for Triaging Stroke Patients Next Year. This test, named LVOne and specifically designed for assessing stroke patients, aims to substantially improve the swiftness and precision of stroke diagnosis in pre-hospital environments. The LVOne test is a rapid blood analysis that enables paramedics to detect strokes caused by large vessel occlusions (LVO) within 15 minutes. This prompt identification is vital for expediting patients to specialized stroke facilities where timely intervention can dramatically better outcomes and lessen long-term disabilities.

Who Are The Firms Contributing To The Lateral Flow Assays Market Ecosystem?

Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics

Access The Complete Lateral Flow Assays Market Report:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Which Region Accounts For The Highest Share Of The Lateral Flow Assays Market?

North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Lateral Flow Assays Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Browse Through More Reports Similar to the Global Lateral Flow Assays Market 2026, By The Business Research Company

Lateral Flow Immunoassay Based Rapid Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Flow Meter Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-meter-global-market-report

Flow Chemistry Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-chemistry-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Lateral Flow Assays Market From 2026 To 2030?

The lateral flow assays market size has exhibited robust growth in recent years. It is projected to expand from $12.29 billion in 2025 to $13.45 billion in 2026, indicating a compound annual growth rate (CAGR) of 9.4%. Historically, this market’s expansion can be attributed to increasing demand for rapid diagnostic solutions, expansion of infectious disease testing, widespread use of rapid test kits, growth of decentralized healthcare delivery, and rising awareness of early disease detection.

The lateral flow assays market is poised for robust expansion in the coming years, with projections indicating a rise to $19.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This anticipated growth during the forecast period is driven by several factors, including the rising acceptance of home-based diagnostics, the broadening integration of digital health, an increasing need for multiplex testing, escalating investments in rapid diagnostic technologies, and a heightened emphasis on real-time disease monitoring. Key trends shaping the market during this period encompass the wider embrace of rapid point-of-care diagnostics, the expanding utilization of multiplex lateral flow assays, the growing incorporation of digital LFA readers, the extension of veterinary and home-based testing solutions, and a stronger emphasis on improving test sensitivity.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6359&type=smp

What Influential Factors Are Boosting The Lateral Flow Assays Market Demand?

The widespread occurrence of infectious diseases across the globe is a significant factor contributing to the expansion of the lateral flow assay market. In developing countries, the high frequency of infectious diseases such as HIV and malaria, alongside inadequate healthcare infrastructure and rising public awareness, is projected to accelerate the uptake of lateral flow assay testing. The recent COVID-19 pandemic has underscored the critical need for early illness detection capabilities, which is expected to fuel market growth. For instance, in August 2024, according to data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023. This represented a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Therefore, the high prevalence of infectious diseases globally will continue to contribute to the growth of the lateral flow assay market.

How Is The Lateral Flow Assays Market Structured Across Different Market Segments?

The lateral flow assays market covered in this report is segmented –

1) By Type: Kits And Reagents, Lateral Flow Readers

2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays

3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents

2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers

What Trends Are Influencing The Lateral Flow Assays Market Outlook?

Leading companies in the lateral flow assay market are concentrating on creating adaptable products, such as lateral flow readers, to enable mobile testing and secure a competitive position. A lateral flow reader, a portable instrument, facilitates rapid and qualitative analysis of lateral flow assays, delivering effective results across diverse testing scenarios. For example, in February 2024, Upfront Diagnostics, a healthcare firm from the UK, introduced the Lateral Flow Test for Triaging Stroke Patients Next Year. This test, named LVOne and specifically designed for assessing stroke patients, aims to substantially improve the swiftness and precision of stroke diagnosis in pre-hospital environments. The LVOne test is a rapid blood analysis that enables paramedics to detect strokes caused by large vessel occlusions (LVO) within 15 minutes. This prompt identification is vital for expediting patients to specialized stroke facilities where timely intervention can dramatically better outcomes and lessen long-term disabilities.

Who Are The Firms Contributing To The Lateral Flow Assays Market Ecosystem?

Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics

Access The Complete Lateral Flow Assays Market Report:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Which Region Accounts For The Highest Share Of The Lateral Flow Assays Market?

North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Lateral Flow Assays Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Browse Through More Reports Similar to the Global Lateral Flow Assays Market 2026, By The Business Research Company

Lateral Flow Immunoassay Based Rapid Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Flow Meter Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-meter-global-market-report

Flow Chemistry Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-chemistry-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Lateral Flow Assays Market Compare Between 2026 And 2030?

The lateral flow assays market has demonstrated strong expansion recently. It is anticipated to increase from $12.29 billion in 2025 to $13.45 billion in 2026, progressing at a compound annual growth rate (CAGR) of 9.4%. The factors contributing to its growth in previous periods include a heightened demand for rapid diagnostic solutions, the broader scope of infectious disease testing, the widespread adoption of rapid test kits, the expansion of decentralized healthcare delivery, and increasing awareness of early disease detection.

The lateral flow assays market size is projected to experience substantial expansion in the coming years, reaching a valuation of $19.3 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.5%. This projected growth during the forecast period is fueled by several factors, including the rising acceptance of home-based diagnostic solutions, broader incorporation of digital health technologies, an increasing need for multiplex testing, greater capital expenditure in swift diagnostic innovations, and an intensified focus on continuous disease tracking. Key trends anticipated over this period encompass the wider utilization of quick point-of-care diagnostics, the growing prevalence of multiplex lateral flow assays, enhanced embedding of digital lfa readers, the extension of testing into veterinary and home settings, and a heightened emphasis on improving test sensitivity.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Which Key Factors Are Driving The Lateral Flow Assays Market Growth?

The widespread occurrence of infectious diseases globally is a major factor driving the expansion of the lateral flow assay market. In developing nations, the frequent incidence of diseases like HIV and malaria, coupled with insufficient healthcare infrastructure and increasing public understanding, is expected to boost the uptake of lateral flow assay testing. The recent COVID-19 pandemic underscored the critical importance of early disease detection, which is anticipated to further propel market growth. A clear example of this trend is seen in England, where in August 2024, data from the UK Health Security Agency (UKHSA), a UK-based executive agency, revealed 368 measles cases in 2023. This figure represents an almost sevenfold surge compared to the 53 cases reported in 2022, with the West Midlands and London contributing 44% and 33% of these cases, respectively. Consequently, the significant prevalence of infectious diseases worldwide is set to fuel the growth of the lateral flow assay market.

What Segment Categories Shape The Lateral Flow Assays Market Segment Landscape?

The lateral flow assays market covered in this report is segmented –

1) By Type: Kits And Reagents, Lateral Flow Readers

2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays

3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents

2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers

Which Trends Are Guiding The Direction Of The Lateral Flow Assays Market?

Leading companies within the lateral flow assay market are concentrating on developing adaptable products, such as lateral flow readers, to enable convenient on-the-go testing and secure a competitive edge. A lateral flow reader functions as a portable instrument, performing rapid and qualitative analysis of lateral flow assays to deliver effective results across diverse testing scenarios. For instance, in February 2024, Upfront Diagnostics, a healthcare firm based in the UK, introduced the Lateral Flow Test for Triaging Stroke Patients Next Year. This specific test, known as LVOne, is engineered for triaging stroke patients with the goal of significantly enhancing the speed and precision of stroke diagnosis outside of hospitals. The LVOne test involves a rapid blood analysis, allowing paramedics to detect strokes resulting from large vessel occlusions (LVO) within a quarter of an hour. Such swift identification is critical for expediting patient transfer to specialized stroke facilities where prompt medical intervention can drastically improve recovery and minimize enduring disabilities.

Who Are The Companies Operating Across The Lateral Flow Assays Market Value Chain?

Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics

Get The Full Lateral Flow Assays Market Report:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Which Region Leads The Lateral Flow Assays Market In Overall Market Size?

North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lateral Flow Assays Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Browse Through More Reports Similar to the Global Lateral Flow Assays Market 2026, By The Business Research Company

Lateral Flow Immunoassay Based Rapid Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Flow Meter Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-meter-global-market-report

Flow Chemistry Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-chemistry-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Lateral Flow Assays Market During The Forecast Period 2026–2030?

The size of the lateral flow assays market has experienced robust expansion over recent years. Projections indicate it will expand from $12.29 billion in 2025 to $13.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.4%. Historically, this growth can be ascribed to a heightened need for swift diagnostic methods, a broader scope of infectious disease screening, the extensive adoption of rapid test kits, the development of decentralized healthcare services, and an increased understanding of the benefits of early disease identification.

The lateral flow assays market size is projected to experience significant expansion in the coming years. It is expected to reach $19.3 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.5%. The projected increase in the forecast period is driven by factors such as the rising acceptance of home-based diagnostic methods, wider integration of digital health solutions, increasing demand for multiplex testing, growing investments in rapid diagnostic technologies, and an amplified focus on real-time disease monitoring. Noteworthy trends anticipated during this period include the increased adoption of rapid point-of-care diagnostics, a surge in the utilization of multiplex lateral flow assays, the growing incorporation of digital LFA readers, the expansion of veterinary and at-home testing, and a stronger emphasis on improving test sensitivity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6359&type=smp

Which Economic Or Industry Drivers Are Impacting The Lateral Flow Assays Market?

A substantial global incidence of infectious diseases significantly drives the expansion of the lateral flow assay market. Specifically, in developing nations, the frequent occurrence of infectious diseases like HIV and malaria, coupled with insufficient healthcare infrastructure and increasing public understanding, is anticipated to quicken the uptake of lateral flow assay testing. The recent COVID-19 pandemic underscored the critical need for prompt illness detection methods, which is expected to propel further market growth. For example, data released by the UK Health Security Agency, a UK executive body, in August 2024, indicated that England’s UKHSA recorded 368 measles cases in 2023, representing an almost sevenfold rise from the 53 cases documented in 2022. The West Midlands contributed 44% and London 33% of these cases. Consequently, the widespread presence of infectious diseases worldwide will continue to foster the expansion of the lateral flow assay market.

What Market Segments Are Evaluated Within The Lateral Flow Assays Market?

The lateral flow assays market covered in this report is segmented –

1) By Type: Kits And Reagents, Lateral Flow Readers

2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays

3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents

2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers

What Industry Trends Are Redefining The Lateral Flow Assays Market?

Leading companies in the lateral flow assay market are concentrating on developing adaptable products, such as lateral flow readers, to offer mobile testing and gain a competitive advantage. A lateral flow reader is a portable device utilized for the rapid and qualitative assessment of lateral flow assays, delivering efficient results in various testing contexts. For example, in February 2024, Upfront Diagnostics, a UK-based healthcare organization, introduced the Lateral Flow Test for Triaging Stroke Patients Next Year. This test, known as LVOne, is specifically engineered for triaging stroke patients and seeks to considerably boost the speed and accuracy of stroke diagnosis in pre-hospital scenarios. The LVOne test is a quick blood examination that allows paramedics to detect strokes caused by large vessel occlusions (LVO) within 15 minutes. This swift identification is essential for promptly directing patients to specialized stroke centers, where opportune treatment can dramatically enhance outcomes and lessen long-term disabilities.

Who Are The Top Market Participants Influencing The Lateral Flow Assays Market?

Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics

Read the full lateral flow assays market report here:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

What Are The Top-Performing Regions Within The Lateral Flow Assays Market?

North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lateral Flow Assays Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6359&type=smp

Browse Through More Reports Similar to the Global Lateral Flow Assays Market 2026, By The Business Research Company

Lateral Flow Immunoassay Based Rapid Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Flow Meter Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-meter-global-market-report

Flow Chemistry Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-chemistry-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Lateral Flow Assays Market expected to grow between 2026 and 2030?

The scale of the lateral flow assays market has experienced robust expansion over the past few years. This market is projected to expand from $12.29 billion in 2025 to reach $13.45 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Historically, this expansion can be primarily attributed to factors such as a heightened need for swift diagnostic methods, the broadening scope of infectious disease screening, the extensive adoption of quick test kits, the rise of distributed healthcare services, and a greater understanding of the benefits of detecting diseases early.

The lateral flow assays market size is projected to experience significant expansion in the coming years. It is forecast to grow to $19.3 billion in 2030, achieving a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period is attributable to factors like the increasing adoption of home-based diagnostics, the broadening integration of digital health, a rising demand for multiplex testing, increased investments in rapid diagnostic technologies, and a heightened focus on real-time disease monitoring. Prominent trends expected in the forecast period include the increasing uptake of rapid point-of-care diagnostics, the growing application of multiplex lateral flow assays, the expanding integration of digital LFA readers, the extension of veterinary and home-based testing, and an enhanced emphasis on test sensitivity.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6359&type=smp

Which Drivers Are Influencing Market Acceleration In The Lateral Flow Assays Market?

A significant driver for the expansion of the lateral flow assay market is the widespread occurrence of infectious diseases worldwide. The adoption of lateral flow assay testing is anticipated to accelerate in developing nations, driven by the frequent incidence of infectious diseases like HIV and malaria, alongside insufficient healthcare infrastructure and increasing public understanding. The recent COVID-19 pandemic underscored the critical requirement for early disease detection tools, which is expected to propel the market forward. To illustrate, in August 2024, data released by the UK Health Security Agency, a UK-based executive body, revealed that in England, the UKHSA documented 368 measles cases during 2023. This represented an almost sevenfold surge from the 53 cases recorded in 2022, with the West Midlands contributing 44% and London 33% of these cases. Consequently, the widespread prevalence of infectious diseases globally will continue to foster the growth of the lateral flow assay market.

What Segments Are Identified Within The Structure Of The Lateral Flow Assays Market?

The lateral flow assays market covered in this report is segmented –

1) By Type: Kits And Reagents, Lateral Flow Readers

2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays

3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents

2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers

Which Trends Are Expected To Influence The Lateral Flow Assays Market In The Upcoming Years?

Leading companies in the lateral flow assay market are concentrating on developing adaptable products, such as lateral flow readers, to provide mobile testing and gain a competitive advantage. A lateral flow reader is a portable instrument utilized for rapid and qualitative evaluation of lateral flow assays, delivering efficient outcomes in various testing environments. For instance, in February 2024, Upfront Diagnostics, a UK-based healthcare company, launched the Lateral Flow Test for Triaging Stroke Patients Next Year. Specifically designed for triaging stroke patients, this test, known as LVOne, aims to significantly enhance the speed and accuracy of stroke diagnosis in pre-hospital settings. The LVOne test is a quick blood test that enables paramedics to identify strokes caused by large vessel occlusions (LVO) within 15 minutes. This swift identification is crucial for fast-tracking patients to specialized stroke centers where timely treatment can drastically improve outcomes and reduce long-term disabilities.

Which Major Industry Participants Are Leading The Lateral Flow Assays Market Growth?

Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Which Region Is Projected To Lead The Lateral Flow Assays Market During The Forecast Period?

North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lateral Flow Assays Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6359&type=smp

Browse Through More Reports Similar to the Global Lateral Flow Assays Market 2026, By The Business Research Company

Lateral Flow Immunoassay Based Rapid Test Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Flow Meter Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-meter-global-market-report

Flow Chemistry Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-chemistry-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the lateral flow assays market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Lateral Flow Assays Market In The Period 2029-2034?

The lateral flow assays market has witnessed significant expansion in recent years. This market is set to expand from $11.69 billion in 2024 to $12.29 billion in 2025, progressing at a compound annual growth rate (CAGR) of 5.2%. The historical growth of this market can be attributed to diagnostic advancements, an increase in infectious diseases, its utilization in pregnancy testing, the rise of home healthcare, the development of immunochromatography, and the broadening reach of point-of-care testing.

The lateral flow assays market size is anticipated to experience substantial expansion over the coming years. This market is projected to reach $17.62 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 9.4%. The projected growth during this period will be driven by the broadening applications in disease detection, the increased adoption of home testing kits, the expansion within veterinary diagnostics, the development of multiplex assays, and a rise in food and environmental testing. Key developments expected during this timeframe encompass the integration of personalized medicine with home testing, advancements in manufacturing techniques, continued emphasis on environmental and food safety testing, a focus on achieving cost-effectiveness, and their application in drug and biomarker detection.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6359&type=smp

What Strategic Drivers Are Accelerating The Lateral Flow Assays Market Expansion?

The widespread occurrence of infectious diseases across the globe significantly contributes to the expansion of the lateral flow assay market. In developing nations, the frequent incidence of infectious diseases such as HIV and malaria, alongside inadequate healthcare systems and increasing public awareness, is projected to hasten the uptake of lateral flow assay testing. The recent COVID-19 pandemic emphasized the necessity for capabilities in early illness detection, which is expected to drive market growth. For instance, in August 2024, according to data published by the UK Health Security Agency, a UK-based executive agency, in England, the UKHSA recorded 368 measles cases in 2023. This marked a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London being responsible for 44% and 33% of the cases, respectively. Consequently, the high prevalence of infectious diseases globally will bolster the growth of the lateral flow assay market.

What Is The Detailed Segment Distribution Of The Lateral Flow Assays Market?

The lateral flow assaysmarket covered in this report is segmented –

1) By Type: Kits And Reagents, Lateral Flow Readers

2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays

3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents

2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers

How Are Global Trends Impacting The Development Of The Lateral Flow Assays Market?

Technological advancements are emerging as prominent and increasingly adopted trends in the lateral flow assays market. Major participants in the lateral flow assay market are prioritizing the development of innovative technological testing products to reinforce their competitive position. For instance, Abacus Diagnostica, a medical device manufacturer based in Finland, unveiled its second-generation COVID-19 test, the GenomEra SARS-CoV-2 2.0 Assay Kit, in February 2022. This assay is specifically designed for the quick qualitative detection of SARS-CoV-2 in respiratory specimens utilizing a multiplex reverse transcriptase polymerase chain reaction (RT-PCR) method.

Who Are The Major Stakeholders Operating In The Lateral Flow Assays Market?

Major companies operating in the lateral flow assays market include Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Lateral Flow Assays Market?

North America was the largest region in the lateral flow assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=6359&type=smp

Browse Through More Reports Similar to the Global Lateral Flow Assays Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Lateral Flow Assays Market By 2029?

The market for lateral flow assays has demonstrated robust expansion over the recent past, projected to escalate from a valuation of $11.69 billion in 2024 to $12.29 billion in 2025, reflecting a consistent compound annual growth rate (CAGR) of 5.2%. This upward trajectory during the historical period is largely credited to several factors, including progress in diagnostic methodologies, an increase in the prevalence of communicable diseases, their widespread use in pregnancy testing procedures, the expansion of home-based healthcare services, innovations in immunochromatography techniques, and the broader adoption of point-of-care testing solutions.

Anticipating robust expansion, the market for lateral flow assays is projected to reach a valuation of $17.62 billion by the year 2029, exhibiting a consistent compound annual growth rate of 9.4% throughout the projected timeframe, a surge fueled by increasing utilization across various fields such as identifying illnesses, the growing acceptance of at-home testing solutions, broader implementation in animal health diagnostics, the creation of multifaceted testing methods, and heightened scrutiny in food and environmental analysis; concurrently, key developments shaping the market landscape involve the shift towards individualized medical care and self-testing accessibility, technological leaps in production methods, greater emphasis on safety checks in both environmental and food sectors, a concentrated effort on optimizing cost efficiency, and the utilization of these assays for identifying pharmaceuticals and biological markers.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6359&type=smp

Which Drivers Are Shaping The Lateral Flow Assays Industry’s Market Share?

Elevated incidences of contagious illnesses worldwide are a major factor driving the expansion of the lateral flow assay market. Particularly in less developed nations, the frequent occurrence of ailments like malaria and HIV, coupled with often insufficient medical infrastructure and growing public consciousness regarding health, is anticipated to speed up the uptake of lateral flow testing methods. Furthermore, the recent global health crisis stemming from COVID-19 emphatically underscored the necessity for rapid diagnostic tools, an element expected to boost market growth further. As an illustrative point, data released in August 2024 by the UK Health Security Agency, an executive body operating within the UK, indicated that England recorded 368 instances of measles in 2023, representing an almost seven-fold surge over the 53 cases documented the preceding year in 2022; notably, the West Midlands and London regions were responsible for 44% and 33% of these reported cases, respectively. Consequently, the widespread nature of infectious diseases internationally serves as a significant driver propelling the lateral flow assay market forward.

Which Key Segments Fueling The Lateral Flow Assays Market?

The lateral flow assaysmarket covered in this report is segmented –

1) By Type: Kits And Reagents, Lateral Flow Readers

2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays

3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents

2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers

What Key Innovation Trends Are Fueling Advancements In The Lateral Flow Assays Market?

Progress in technology represents the primary movement gathering momentum within the market for lateral flow assays, with major companies active in this sector concentrating their efforts on creating groundbreaking testing solutions to bolster their standing. Illustratively, in February of 2022, Abacus Diagnostica, a firm based in Finland specializing in medical device production, introduced its next-generation COVID-19 diagnostic tool, the GenomEra SARS-CoV-2 2.0 Assay Kit; this specific assay facilitates the swift, descriptive identification of SARS-CoV-2 found in respiratory samples by employing a multiplex reverse transcriptase polymerase chain reaction (RT-PCR) technique.

Which Key Players Are Driving Competition In The Lateral Flow Assays Market?

Major companies operating in the lateral flow assays market include Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

How Do Regional Market Performances Compare Within The Lateral Flow Assays Industry?

North America was the largest region in the lateral flow assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Lateral Flow Assays Market Report:

https://www.thebusinessresearchcompany.com/customise?id=6359&type=smp

Browse Through More Reports Similar to the Global Lateral Flow Assays Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Lateral Flow Assays Market, and What Factors Will Drive It?

In the past few years, the lateral flow assays market has seen significant growth. The market size is predicted to increase from $11.69 billion in 2024 to $12.29 billion in 2025, featuring a compound annual growth rate (CAGR) of 5.2%. The growth witnessed in the historical period is due to advancements in diagnostics, a surge in infectious diseases, utilization in pregnancy testing, expansion in home health care, progress in immunochromatography, and the growth of point-of-care testing.

The market size for lateral flow assays is predicted to experience significant expansion in the coming years, potentially reaching $17.62 billion by 2029, with a CAGR of 9.4%. The projected growth during the forecast period can be attributed to several factors such as advancements in disease detection applications, prevalence of home testing kits, growth in veterinary diagnostics, development of multiplex assays, and an increase in food and environmental testing. The forecast period is also expected to witness trends like personalized medicine and home testing, improved manufacturing techniques, emphasis on environmental and food safety testing, cost-effectiveness, and the application in drug and biomarker detection.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6359&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Lateral Flow Assays Market?

The worldwide pervasiveness of infectious diseases significantly drives the growth of the lateral flow assay market. The recurrent occurrence of diseases like HIV and malaria in developing nations, along with a deficient healthcare system and heightened public awareness, is anticipated to speed up the utilisation of lateral flow assay testing methods. The recent COVID-19 pandemic has underscored the requirement for advanced disease detection, which is expected to boost the market size. For instance, in 2024, the UK Health Security Agency, an executive agency based in the UK, released data indicating an almost sevenfold increase in measles incidents in England from the previous year. There were 368 cases in 2023 compared to 53 in 2022, with notable incidences in the West Midlands and London, representing 44% and 33% of cases, respectively. Hence, the global spread of infectious diseases will largely influence the growth of the lateral flow assay market.

Which Primary Segments of the Lateral Flow Assays Market Are Driving Growth and Industry Transformations?

The lateral flow assaysmarket covered in this report is segmented –

1) By Type: Kits And Reagents, Lateral Flow Readers

2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays

3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents

2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6359&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Lateral Flow Assays Market?# Market?

North America was the largest region in the lateral flow assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Lateral Flow Assays Market?

Progress in technology is the leading trend gaining traction in the lateral flow assays market. To solidify their market position, major market participants are concentrating on the creation of technologically advanced testing products. For example, in February 2022, Abacus Diagnostica, a medical device manufacturer based in Finland, introduced their second generation COVID-19 test titled, the GenomEra SARS-CoV-2 2.0 Assay Kit. This assay is devised for quick qualitative identification of SARS-CoV-2 in respiratory samples through a multiplex reverse transcriptase polymerase chain reaction (RT-PCR) method.

View the full report here:

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

What Parameters Are Used to Define the Lateral Flow Assays Market?

A lateral flow assay (LFA) is made up of four parts: a sample pad where the sample is dropped, a conjugate pad where labelled tags and biorecognition elements are combined, a reaction membrane with test and control lines for target antigen-antibody interaction, and an absorbent pad where waste is stored.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6359

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model